In the latest close session, Recursion Pharmaceuticals (RXRX) was down 4.64% at $4.73. The stock's performance was behind the ...

Many in the AI community believe that the next major revolution will be the era of self-improving AI where AI can improve ...

Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...

Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the market? This article walks through what the current numbers may be telling ...

Dario Amodei’s prediction from last year of AI writing 90% of code appears to have largely come true, and has an even ...

Modern cells are complex chemical entities with cytoskeletons, finely regulated internal and external molecules, and genetic ...

Companies that postpone offtake discussions often discover that scale capital remains inaccessible when it is most needed.

A recent large longitudinal study found that early dynamics with mothers predicted future attachment styles across all ...

Generative AI was trained on centuries of art and writing produced by humans. But scientists and critics have wondered what would happen once AI became widely adopted and started training on its ...

Surface Design Show 2026 reaffirms its commitment to nurturing emerging design talent, placing material innovation, ...

Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...

DeFi has evolved from 2020’s yield chaos into real financial infrastructure. Here’s how stablecoins, RWAs, and institutions ...